Sprout Pharmaceuticals Appeals FDA Decision on New Drug Application for …

Published December 13, 2013

Sprout Pharmaceuticals Appeals FDA Decision On New Drug Application For …
RALEIGH, N.C., Dec. 11, 2013 /PRNewswire/ — Sprout Pharmaceuticals today announced that it has received and appealed the Food and Drug Administration's (FDA) Complete Response Letter (CRL) for flibanserin through the Formal Dispute Resolution process … Read more on PR Newswire (press release)

Sticky sensors help patients and doctors manage at-home cancer treatment plans
She previously worked as an innovation and commercialization adviser at RTI International and the NC Biotechnology Center. … Health was more interesting to me than the latest version of Windows, so I left for a startup tracking prescription drug news … Read more on MedCity News

SmallCapReview Initiates Coverage of Coronado Biosciences (CNDO)
Announced that Dr. Eric Hollander, Clinical Professor of Psychiatry and Behavioral Sciences at Albert Einstein College of Medicine of Yeshiva University and Director of the Autism and Obsessive Compulsive Spectrum Program at Montefiore Medical Center … Read more on SBWire (press release)

Answer Man: Can cleft palate and lip be prevented?
That adds up to roughly 7,000 babies every year, making it the nation's most common birth defect, according to the Centers for Disease Control and Prevention. … Most certainly, there is a genetic component, Lisa Gist Walker at the Cleft Palate … Read more on Belleville News Democrat